CAELUM Co., Ltd. (KOSDAQ:258610)
1,600.00
-20.00 (-1.23%)
At close: Mar 20, 2026
CAELUM Revenue
CAELUM had revenue of 21.79B KRW in the quarter ending September 30, 2025, a decrease of -19.54%. This brings the company's revenue in the last twelve months to 88.69B, up 2.99% year-over-year. In the year 2024, CAELUM had annual revenue of 97.33B with 15.12% growth.
Revenue (ttm)
88.69B
Revenue Growth
+2.99%
P/S Ratio
0.65
Revenue / Employee
2.33B
Employees
38
Market Cap
57.96B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 97.33B | 12.78B | 15.12% |
| Dec 31, 2023 | 84.55B | 6.70B | 8.61% |
| Dec 31, 2022 | 77.84B | 24.92B | 47.09% |
| Dec 31, 2021 | 52.92B | 41.43B | 360.57% |
| Dec 31, 2020 | 11.49B | -8.98B | -43.87% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| S.NetSystems.Inc. | 428.54B |
| Guyoung Technology | 387.53B |
| Openbase | 239.47B |
| Hyunwoo Industrial Co., LTD | 221.92B |
| Cenit | 128.74B |
| Jin Yang Pharmaceutical | 117.19B |
| Cell Bio Human Tech Co.,Ltd | 45.07B |
| PlayD | 36.83B |